[Reprint of: New guidelines for stage III melanoma (the French Cutaneous Oncology Group)].

[Reprint of: New guidelines for stage III melanoma (the French Cutaneous Oncology Group)].
Bull Cancer. 2019 May 20;:
Authors: Guillot B, Dupuy A, Pracht M, Jeudy G, Hindie E, Desmedt E, Jouary T, Leccia MT
Abstract
Improved knowledge of sentinel node procedures coupled with the results of adjuvant clinical trials in stage III melanoma have prompted the French Cutaneous Oncology Group to propose new guidelines for the management of stage III melanoma. These guidelines comply with the principles of the evidence-based medicine.
PMID: 31122657 [PubMed - as supplied by publisher]

Source: Bulletin du Cancer - May 19, 2019 Category: Cancer & Oncology Authors: Guillot B, Dupuy A, Pracht M, Jeudy G, Hindie E, Desmedt E, Jouary T, Leccia MT Tags: Bull Cancer Source Type: research